** Cambium Bio CMB.AX jumps 13% to A$0.52, highest since November 27, 2025
** Regenerative medicine co secures A$2.4 million strategic investment from major shareholder Zheng Yang Biomedical Technology Co
** Investment via placement of 4.4 mln new shares at A$0.55/share, representing 19.6% premium to last close
** YTD, CMB up 10.6%
(Reporting by Shruti Agarwal in Bengaluru)
((Shruti.Agarwal@thomsonreuters.com))